Navigation Links
DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
Date:2/12/2008

RALEIGH, N.C. and WELLESLEY HILLS, Mass., Feb. 12 /PRNewswire/ -- DARA BioSciences, Inc. ("DARA") and Point Therapeutics, Inc. ("Point") (Nasdaq: POTP) announced the consummation of their merger transaction, effective as of the close of business on February 12, 2008.

The merger was completed after approval by the respective stockholders of DARA and Point. Immediately prior to the consummation of the merger, Point effected a reverse stock split of its common stock pursuant to which each 40 shares of Point common stock issued and outstanding was converted into one share of Point common stock. As a result of the merger, DARA stockholders will receive 1.031406 shares of Point common stock for each share of DARA common stock and preferred stock held immediately prior to the transaction.

In making the announcement, DARA's Chairman Richard A. Franco, Sr., commented, "We are pleased to have completed this transaction and appreciate the confidence of the stockholders of DARA and Point as evidenced by their votes."

Upon consummation of the merger, DARA became a wholly-owned subsidiary of Point, and Point changed its name to DARA BioSciences, Inc. The combined company's common stock will continue to trade on the NASDAQ Capital Market under the symbol "DARA ". Additionally, the Board of Directors and executive officers of DARA will lead the combined company.

About DARA BioSciences, Inc.

DARA BioSciences(TM), Inc. ("DARA") is a Raleigh, North Carolina-based development-stage pharmaceutical company that acquires promising therapeutic molecules and medical technologies directly or through investment in established companies. DARA focuses its therapeutic development efforts on small molecules from late preclinical development through phase 2 clinical trials. DARA is developing a portfolio of therapeutic candidates for neuropathic pain, metabolic diseases including type 2 diabetes, and dermatological disorders. DARA has licensed promising drug development candidates from Kirin Pharmaceuticals of Japan, Bayer Pharmaceuticals Corporation, Massachusetts General Hospital and Nuada LLC.

As of February 13, 2008, DARA will trade on the NASDAQ Capital Market under the ticker symbol "DARA".

For more information please contact the Company at 919-872-5578 or visit our web site at http://www.darabiosciences.com.


'/>"/>
SOURCE DARA BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pressure BioSciences, Inc. Reports Third Quarter 2007 Financial Results and Provides Business Update
2. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
3. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
4. Jill Birkett Appointed Event Director for HBA Global Expo
5. USHEALTH Group Announces Appointment of Executive Vice President
6. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
7. Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
8. AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors
9. Natural Alternatives International, Inc. Appoints New Chief Financial Officer
10. Deerfield Spa Appoints New Fitness Director
11. Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2018)... ... August 14, 2018 , ... Kathy Mills ... at ChiroTouch Connect User Conference. The ChiroTouch Conference is a one-day learning event ... , ChiroTouch is ecstatic to have Kathy Mills Chang lead the conference. Kath ...
(Date:8/14/2018)... (PRWEB) , ... August 14, 2018 , ... ... investment in the Recreational Group, a leading provider of residential and commercial recreational ... turf and sports surfacing industry, with products used across a wide range of ...
(Date:8/11/2018)... ... August 10, 2018 , ... Johns Hopkins All Children’s Hospital ... the region by utilizing a population health perspective on care. At its core, this ... are being treated at the right facility or setting at the right cost. Mark ...
(Date:8/9/2018)... and SEATTLE (PRWEB) , ... August 09, 2018 , ... ... US cases reported per year skyrocketing to an estimated 329,000 – a 25-fold increase ... Health Trends™ , Lyme disease can be found all 50 states and the District ...
(Date:8/9/2018)... ... August 09, 2018 , ... ... Kathy Coover and the company’s independent distributors, customers, and employees, the newly established ... of fundraising, exceeding the $2 million goal. 100 percent of the donations will ...
Breaking Medicine News(10 mins):
(Date:8/14/2018)... ... August 14, 2018 , ... Children’s National Health System ... $270,000 to expand a popular pet therapy program. , The grant will ... more visits to patients throughout the hospital and outpatient clinics. With this critical ...
(Date:8/11/2018)... FRANCISCO (PRWEB) , ... August 11, 2018 , ... ... Handers Day on Monday, August 13, with fun, games and gifts. Left-Handers are ... a world designed for right-handers. Having endured centuries of prejudice, countless indignities and ...
(Date:8/9/2018)... ... August 09, 2018 , ... Doctor Snehal Patel is offering the ... smiles. From now until September 30th, applicants who are in need of full-arch restorations, ... Implant & Oral Surgery's Project Smile Program. , "Our local communities have been very ...
Breaking Medicine Technology: